摘要
目的:探讨实施临床路径后对2型糖尿病患者的影响。方法:选择某三甲医院2011年前未实施临床路径和2011年实施临床路径后诊断为2型糖尿病的患者,观察比较实施临床路径前后2型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2型糖尿病治愈、好转、死亡等效果等指标有无差异。结果:实施临床路径前后2型糖尿病患者的平均住院日、再住院率、住院费用、药费、耗材费、检查费以及2型糖尿病治愈、好转、死亡等效果相比较有明显差异(P<0.01)。结论:2型糖尿病人治疗中实施临床路径可显著缩短平均住院日,降低平均住院费、药费、耗材费及检查费用,再住院率明显降低,实施临床路径后2型糖尿病治愈、好转、死亡等效果比实施临床路径前明显改善。临床路径的开展和应用,使患者在最合适的时机得到最合理的检测、诊断和治疗,大大优化医疗资源,改善治疗结局,具有临床应用价值,值得临床推广和应用。
Objective: To investigate the effect of the clinical pathway on patients with type 2 diabetes mellitus. Methods: The patients with type 2 diabetes patients without implemented the clinical pathway before and performed the clinical pathway in 2011 were chosen, then the difference in average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death were detectedq. Results: After perform the clinical pathway on patients with type 2 diabetes, the average day in hospital, hospital admission rates again, hospital cost, expenses for medicine, material fee, examination fee and type 2 diabetes cure rate, improvement, death effects had obvious difference (P〈0.01). Conclusion: Perform clinical pathway on patients with type 2 diabetes can significantly shorten the average day in hospital, reduce the average hospitalization expenses, expenses for medicine, material fee and checking expenses, and the hospitalization rate was reduced significantly. The development and application of clinical pathway can optimize medical resources, improve the treatment outcome, with a great clinical application value.
出处
《现代生物医学进展》
CAS
2014年第8期1518-1521,共4页
Progress in Modern Biomedicine
关键词
2型糖尿病
临床路径
影响
Type 2 diabetes
Clinical pathway
Influence